Research article · 16 Feb 2026
Review articlePublished 2013
Aberrations in Angiogenic Signaling and MYC Amplifications are Distinguishing Features of Angiosarcoma
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Angiosarcomas are very aggressive, rare malignant tumors that originate from vascular or lymphatic vessels and primarily occur following chemical exposure or radiation therapy. Tumor response to either chemotherapy, radiation, or novel anti-angiogenic therapeutics is very low, and because little is known regarding the aberrant signaling that controls these tumors, personalized treatment options for many of these patients are lacking. In this review, we summarize several recent findings regarding the genomics of angiosarcomas, including new discoveries regarding aberrant angiogenic signaling and Myc amplification as key features of this tumor type.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Angiology: Open Access.
Research article · 16 Feb 2026
Risk Prediction Models for Autogenous Arteriovenous Fistula Maturation Failure in Patients with End-Stage Renal Disease: A Systematic Review and Meta-Analysis
Short communication · 19 Dec 2025
Innovations in Venous Insufficiency Treatment Comparing the Efficacy of Endovenous Laser and Radiofrequency Ablation
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAngiology: Open Access
- BylineArticles whose byline prints “Vittal Kurisetty”
- BylineArticles whose byline prints “Brad A Bryan”
